Dr. Richard Sackler, a Member of the Family Behind the Current Opioid Epidemic, Was Granted a Patent for Yet Another Drug to Treat Drug Addiction

  • Save
  • Save

Dr. Richard Sackler, former president of Purdue Pharma, the drug company that ignited the opioid epidemic through aggressive marketing of OxyContin, was awarded a patent for the treatment of opioid addiction, and the FDA has approved the drug. Recently, the company was ordered to pay $635-million after three of its top executives plead guilty to misleading doctors about the addictive nature of OxyContin. In October, President Trump declared that the opioid epidemic was a nationwide public-health emergency inasmuch as 300,000 Americans have died from opioid overdoses since 2000. The $635-million fine represents less than one-fourth the sales revenue OxyContin generated for the Sacklers. -GEG

A former president of Purdue Pharma, the controversial drug manufacturer widely considered to have ignited the opioid epidemic through its aggressive marketing of OxyContin, has been awarded a patent for a new opioid addiction treatment.

Dr. Richard Sackler is one of the six individuals on the patent issued in January, the Financial Times first reported Friday. Critics expressed concern that Sackler, whose family is worth an estimated $13 billion largely from Purdue’s sale of opioid painkillers, now stands to profit further from medication that treats addiction to the very drugs peddled by his family.

The patent covers a new formulation of buprenorphine in a wafer form. The medication is shown to help people struggling with opioid addiction, and the Food and Drug Administration has already approved the drug in tablet and film form.

President Donald Trump declared the opioid epidemic a nationwide public health emergency in October, citing more than 300,000 Americans who have died from opioid overdoses since 2000.

Sackler, who served as Purdue’s president from 1999 to 2003, was instrumental in pushing OxyContin’s sales through one of the largest pharmaceutical marketing campaigns in history. The campaign worked: Doctors previously averse to prescribing opioids for pain management due to their addictiveness were convinced by Purdue’s aggressive tactics that OxyContin was safe to prescribe.

Purdue later admitted that its marketing campaign was a sham.

The company was ordered to pay $635 million after it and three top executives pleaded guilty to misleading doctors about the addictiveness of OxyContin and its potential for abuse between 1996 and 2001. Put into perspective, the fine represents less than one-quarter of the sales revenue OxyContin generated for the Sacklers during that six-year period.

Read full article here…

Visit our Classified ads.

Check out our Classified ads at the bottom of this page.

Recent stories & commentary


For classified advertising rates and terms, click here. The appearance of ads on this site does not signify endorsement by the publisher. We do not attempt to verify the accuracy of statements made therein or vouch for the integrity of advertisers. However, we will investigate complaints from readers and remove any message we find to be misleading or that promotes anything fraudulent, illegal, or unethical.

Notify of
Inline Feedbacks
View all comments